Colgate-Palmolive (NYSE:CL - Get Free Report) had its target price reduced by investment analysts at TD Cowen from $110.00 to $100.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. TD Cowen's price target suggests a potential upside of 14.43% from the company's current price.
A number of other brokerages also recently weighed in on CL. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Wednesday, January 1st. Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their target price for the company from $105.00 to $101.00 in a report on Monday, October 28th. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Piper Sandler lowered their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday. Finally, Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $103.63.
Get Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Price Performance
Shares of CL remained flat at $87.39 during midday trading on Wednesday. 5,063,919 shares of the stock traded hands, compared to its average volume of 4,441,603. The stock has a market cap of $71.40 billion, a PE ratio of 25.04, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The firm has a 50 day moving average price of $93.03 and a 200 day moving average price of $98.31. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30.
Insider Activity
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.34% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in CL. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $53,000. Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $64,000. True Wealth Design LLC grew its position in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company's stock valued at $75,000 after purchasing an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC increased its stake in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock valued at $79,000 after buying an additional 368 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.
About Colgate-Palmolive
(
Get Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.